Strategic investment to support RBL’s mission to launch and scale breakthrough startups Founder and general partner of Modi Ventures, Sahir Ali, to join RBL board of...
The American College of Emergency Physicians (ACEP) is pleased to announce Michael Fraser, PhD, MS, CAE as its next executive director. Fraser will lead the implementation...
CorMedix to pay Melinta $300 million in upfront consideration, comprised of $260 million in cash and $40 million in CorMedix equity issued to Melinta shareholders...
Advancing Eyecare (“AEC”), a leading provider of ophthalmic instruments in North America, today announced the acquisition of Birmingham Optical Group (“Birmingham Optical” or the “Company”), a leading...
Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the appointment of two highly distinguished leaders to its Board of Directors: Josephine M....
Steven Sell steps down as President, Chief Executive Officer, and Board Director Ronald A. Williams, co-founder, Board Chairman, and healthcare industry veteran, appointed Executive Chairman...
Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition. Mary Gunn has stepped down effective immediately. The Board has appointed Glenn Kerkhof, a...
IMV, part of the Science and Medicine Group and the leading market research and business intelligence provider to the laboratory diagnostic industry, is pleased to...
Once again on the Honor Roll of America’s Top 20 Hospitals, NYU Langone was evaluated alongside more than 4,500 medical centers nationally NYU Langone Health...
Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies,...
iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of two Non-Executive Directors to its Board. Joining the Board...
Alongside a recent capital raise, the company announced Chief Strategy Officer Jason Macaleer will partner with Chief Growth Officer Mike Rolla to meet growing demand...
Clinicians, innovators, and industry experts will join the current leadership to harness recent investments and initiatives to empower clients with unmatched choices, flexibility, and control...